During the past decade, Pharmacology and toxicology department, UANL conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pharmacology and toxicology department, UANL" are "Healthy" (2 trials). Many other conditions were trialed in "Pharmacology and toxicology department, UANL" in a lesser frequency.

Most popular intervention types in "Pharmacology and toxicology department, UANL" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "DMMET-01" (1 trials), "metformin" (1 trials) and "metformin ER" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pharmacology and toxicology department, UANL" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Pharmacology and toxicology department, UANL". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pharmacology and toxicology department, UANL, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pharmacology and toxicology department, UANL, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".